SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DOSE(capstone pharm) -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (87)10/15/1998 9:10:00 PM
From: Rob Anderson  Read Replies (1) | Respond to of 92
 
DAK I own DOSE from 4-6.00 I wish I had waited but still believe im in good shape I have nothing but time to wait on this one! Starman posted on YAHOO that part of the book value on DOSE is good will. WRONG!
This is Assetts minus liabilities divided by shares.

This from market guide report 6/30/98 balance sheet.

They had at that time $3.32 per share in cash and recievables!

DAK your in big time at $3.25 congratulations on a very astute transaction!

Rob